EP1545209A4 - Factors that bind intestinal toxins - Google Patents

Factors that bind intestinal toxins

Info

Publication number
EP1545209A4
EP1545209A4 EP03749554A EP03749554A EP1545209A4 EP 1545209 A4 EP1545209 A4 EP 1545209A4 EP 03749554 A EP03749554 A EP 03749554A EP 03749554 A EP03749554 A EP 03749554A EP 1545209 A4 EP1545209 A4 EP 1545209A4
Authority
EP
European Patent Office
Prior art keywords
factors
intestinal toxins
bind intestinal
bind
toxins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03749554A
Other languages
German (de)
French (fr)
Other versions
EP1545209A2 (en
Inventor
Joel Moss
Masatoshi Noda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiba University NUC
US Department of Health and Human Services
Original Assignee
Chiba University NUC
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiba University NUC, US Department of Health and Human Services filed Critical Chiba University NUC
Publication of EP1545209A2 publication Critical patent/EP1545209A2/en
Publication of EP1545209A4 publication Critical patent/EP1545209A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP03749554A 2002-09-10 2003-09-09 Factors that bind intestinal toxins Withdrawn EP1545209A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40974202P 2002-09-10 2002-09-10
US409742P 2002-09-10
PCT/US2003/028282 WO2004024070A2 (en) 2002-09-10 2003-09-09 Factors that bind intestinal toxins

Publications (2)

Publication Number Publication Date
EP1545209A2 EP1545209A2 (en) 2005-06-29
EP1545209A4 true EP1545209A4 (en) 2009-07-29

Family

ID=31993998

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03749554A Withdrawn EP1545209A4 (en) 2002-09-10 2003-09-09 Factors that bind intestinal toxins

Country Status (5)

Country Link
EP (1) EP1545209A4 (en)
JP (1) JP2006508924A (en)
AU (1) AU2003267079B2 (en)
CA (1) CA2498225A1 (en)
WO (1) WO2004024070A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003237800A1 (en) 2002-04-05 2003-10-27 Government Of The United States, As Represented Bythe Secretary Of The Army Polymeric antioxidants
US20060041087A1 (en) 2004-07-23 2006-02-23 Cholli Ashok L Anti-oxidant macromonomers and polymers and methods of making and using the same
EP1817393A2 (en) 2004-12-03 2007-08-15 Polnox Corporation Process for the synthesis of polyalkylphenol antioxidants
EP1828104A1 (en) 2004-12-03 2007-09-05 Polnox Corporation Synthesis of aniline and phenol-based antioxidant macromonomers and corresponding polymers
EP1861484A2 (en) 2005-02-22 2007-12-05 Polnox Corporation Nitrogen and hindered phenol containing dual functional macromolecular antioxidants: synthesis , performances and applications
US7705185B2 (en) 2005-03-25 2010-04-27 Polnox Corporation Alkylated and polymeric macromolecular antioxidants and methods of making and using the same
WO2006116532A2 (en) * 2005-04-28 2006-11-02 University Of Massachusetts Lowell Synthesis of oligo/poly(catechins) and methods of use
WO2007050985A2 (en) 2005-10-27 2007-05-03 Polnox Corporation Macromolecular antioxidants based on stξrically hindered phenolic phosphites
US20070149660A1 (en) 2005-10-27 2007-06-28 Vijayendra Kumar Stabilized polyolefin compositions
EP1963468A1 (en) 2005-12-02 2008-09-03 Polnox Corporation Lubricant oil compositions
US8178135B2 (en) 2006-03-07 2012-05-15 Keio University Aqueous solution of conophylline and/or conophyllidine
WO2008005358A2 (en) 2006-07-06 2008-01-10 Polnox Corporation Novel macromolecular antioxidants comprising differing antioxidant moieties: structures, methods of making and using the same
US7767853B2 (en) 2006-10-20 2010-08-03 Polnox Corporation Antioxidants and methods of making and using the same
JP2012153659A (en) * 2011-01-27 2012-08-16 Akita Univ Humulus lupulus leaf extract and method for producing the same
JP6232177B2 (en) * 2011-11-28 2017-11-15 花王株式会社 Verotoxin deactivator
WO2015077635A2 (en) 2013-11-22 2015-05-28 Polnox Corporation Macromolecular antioxidants based on dual type moiety per molecule: structures methods of making and using the same
WO2018160879A2 (en) 2017-03-01 2018-09-07 Polnox Corporation Macromolecular corrosion (mcin) inhibitors: structures, methods of making and using the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2330076A (en) * 1997-10-10 1999-04-14 Steiner Inc S S Use of hop extracts against botulism
JP2001321166A (en) * 2000-05-17 2001-11-20 Asahi Breweries Ltd Lipase inhibitor obtained from hop

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2986805B2 (en) * 1989-05-19 1999-12-06 三井農林株式会社 Antitoxin for bacterial exotoxin
EP1153604A4 (en) * 1999-02-15 2003-07-30 Nikka Whisky Distilling Co Ltd Adp-ribosylation inhibitors and remedies for endotoxic bacterial enteric infection containing proanthocyanidin as the active ingredient
JP2000342192A (en) * 1999-06-08 2000-12-12 Natl Fedelation Of Agricult Coop Assoc Feed as countermeasure for edema
JP2001249134A (en) * 1999-12-28 2001-09-14 Matsushita Electric Ind Co Ltd Reagent for measuring protein concentration, method for measuring protein concentration using it, and urinalysis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2330076A (en) * 1997-10-10 1999-04-14 Steiner Inc S S Use of hop extracts against botulism
JP2001321166A (en) * 2000-05-17 2001-11-20 Asahi Breweries Ltd Lipase inhibitor obtained from hop

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MORINAGA NAOKO ET AL: "Differential activities of plant polyphenols on the binding and internalization of cholera toxin in vero cells", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 280, no. 24, June 2005 (2005-06-01), pages 23303 - 23309, XP002531884, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
WO2004024070A2 (en) 2004-03-25
AU2003267079A1 (en) 2004-04-30
JP2006508924A (en) 2006-03-16
AU2003267079B2 (en) 2008-08-14
EP1545209A2 (en) 2005-06-29
WO2004024070A3 (en) 2004-08-05
CA2498225A1 (en) 2004-03-25

Similar Documents

Publication Publication Date Title
HK1069007A1 (en) Overlapping conderser
EP1572131A4 (en) Antibody therapy
EP1494693A4 (en) Cripto-specific antibodies
AU2003216341A8 (en) Mhc-peptide complex binding ligands
IL174020A0 (en) Antigen-scaffold complexes
GB0200891D0 (en) Hydrocarbons
PT1599504E (en) Modified antibody
PL375405A1 (en) Antibodies
AU2003213647A8 (en) Multimeric binding complexes
EP1545209A4 (en) Factors that bind intestinal toxins
AU2003272511A8 (en) Cd44-binding ligands
IL166361A0 (en) Binding molecules
GB0307206D0 (en) Hyperproliferation
EP1677112A4 (en) Immunoassay
GB2409838B (en) Bookmark
GB0305448D0 (en) Immunoassay
PT1497496E (en) Valuable document
EP1541290A4 (en) Stapler
HK1080089A1 (en) Rhamnose binding protein
GB0226374D0 (en) Ligands
GB2395682B (en) Book manufacture
GB2393687B (en) Punchless file
GB2386087B (en) Stapler
GB0204921D0 (en) Note book
GB0209232D0 (en) Adsorbents

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050408

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20090629

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090929